Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742) von Ma, Brigette B Y, Lim, Wan-Teck, Goh, Boon-Cher, Hui, Edwin P, Lo, Kwok-Wai, Pettinger, Adam, Foster, Nathan R, Riess, Jonathan W, Agulnik, Mark, Chang, Alex Y C, Chopra, Akhil, Kish, Julie A, Chung, Christine H, Adkins, Douglas R, Cullen, Kevin J, Gitlitz, Barbara J, Lim, Dean W, To, Ka-Fai, Chan, K C Allen, Lo, Y M Dennis, King, Ann D, Erlichman, Charles, Yin, Jun, Costello, Brian A, Chan, Anthony T C

Volltext

Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases von Mack, Philip C., Banks, Kimberly C., Espenschied, Carin R., Burich, Rebekah A., Zill, Oliver A., Lee, Christine E., Riess, Jonathan W., Mortimer, Stefanie A., Talasaz, AmirAli, Lanman, Richard B., Gandara, David R.

Volltext

Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers von Blakely, Collin M, Watkins, Thomas B K, Wu, Wei, Gini, Beatrice, Chabon, Jacob J, McCoach, Caroline E, McGranahan, Nicholas, Wilson, Gareth A, Birkbak, Nicolai J, Olivas, Victor R, Rotow, Julia, Maynard, Ashley, Wang, Victoria, Gubens, Matthew A, Banks, Kimberly C, Lanman, Richard B, Caulin, Aleah F, St John, John, Cordero, Anibal R, Giannikopoulos, Petros, Simmons, Andrew D, Mack, Philip C, Gandara, David R, Husain, Hatim, Doebele, Robert C, Riess, Jonathan W, Diehn, Maximilian, Swanton, Charles, Bivona, Trever G

Volltext

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC von Riess, Jonathan W., Gandara, David R., Frampton, Garrett M., Madison, Russell, Peled, Nir, Bufill, Jose A., Dy, Grace K., Ou, Sai-Hong Ignatius, Stephens, Philip J., McPherson, John D., Lara, Primo N., Burich, Rebekah A., Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Mack, Philip C., Schrock, Alexa B.

Volltext

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations von Rich, Thereasa A, Reckamp, Karen L, Chae, Young Kwang, Doebele, Robert C, Iams, Wade T, Oh, Michael, Raymond, Victoria M, Lanman, Richard B, Riess, Jonathan W, Stinchcombe, Thomas E, Subbiah, Vivek, Trevarthen, David R, Fairclough, Stephen, Yen, Jennifer, Gautschi, Oliver

Volltext

Diffuse High Intensity PD–L1 Staining in Thymic Epithelial Tumors von Padda, Sukhmani K., Riess, Jonathan W., Schwartz, Erich J., Tian, Lu, Kohrt, Holbrook E., Neal, Joel W., West, Robert B., Wakelee, Heather A.

Volltext

A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors von Jahchan, Nadine S, Dudley, Joel T, Mazur, Pawel K, Flores, Natasha, Yang, Dian, Palmerton, Alec, Zmoos, Anne-Flore, Vaka, Dedeepya, Tran, Kim Q T, Zhou, Margaret, Krasinska, Karolina, Riess, Jonathan W, Neal, Joel W, Khatri, Purvesh, Park, Kwon S, Butte, Atul J, Sage, Julien

Volltext

Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins von Neel, Dana S, Allegakoen, David V, Olivas, Victor, Mayekar, Manasi K, Hemmati, Golzar, Chatterjee, Nilanjana, Blakely, Collin M, McCoach, Caroline E, Rotow, Julia K, Le, Anh, Karachaliou, Niki, Rosell, Rafael, Riess, Jonathan W, Nichols, Robert, Doebele, Robert C, Bivona, Trever G

Volltext

Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions von Floc'h, Nicolas, Martin, Matthew J, Riess, Jonathan W, Orme, Jonathan P, Staniszewska, Anna D, Ménard, Ludovic, Cuomo, Maria Emanuela, O'Neill, Daniel J, Ward, Richard A, Finlay, M Raymond V, McKerrecher, Darren, Cheng, Mingshan, Vang, Daniel P, Burich, Rebekah A, Keck, James G, Gandara, David R, Mack, Philip C, Cross, Darren A E

Volltext

Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database von Padda, Sukhmani K., Yao, Xiaopan, Antonicelli, Alberto, Riess, Jonathan W., Shang, Yue, Shrager, Joseph B., Korst, Robert, Detterbeck, Frank, Huang, James, Burt, Bryan M., Wakelee, Heather A., Badve, Sunil S.

Volltext

Toward Nanowire Electronics von Appenzeller, J., Knoch, J., Bjork, M.T., Riel, H., Schmid, H., Riess, W.

Volltext

Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer von Lopez de Rodas, Miguel, Nagineni, Venkata, Ravi, Arvind, Datar, Ila J, Mino-Kenudson, Mari, Corredor, German, Barrera, Cristian, Behlman, Lindsey, Rimm, David L, Herbst, Roy S, Madabhushi, Anant, Riess, Jonathan W, Velcheti, Vamsidhar, Hellmann, Matthew D, Gainor, Justin, Schalper, Kurt A

Volltext

Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial von Monjazeb, Arta M., Daly, Megan E., Luxardi, Guillaume, Maverakis, Emanual, Merleev, Alexander A., Marusina, Alina I., Borowsky, Alexander, Mirhadi, Amin, Shiao, Stephen L., Beckett, Laurel, Chen, Shuai, Eastham, David, Li, Tianhong, Vick, Logan V., McGee, Heather M., Lara, Frances, Garcia, Leslie, Morris, Leigh Anne, Canter, Robert J., Riess, Jonathan W., Schalper, Kurt A., Murphy, William J., Kelly, Karen

Volltext

Outperforming the Conventional Scaling Rules in the Quantum-Capacitance Limit von Knoch, J., Riess, W., Appenzeller, J.

Volltext

Silicon nanowire tunneling field-effect transistors von Björk, M. T., Knoch, J., Schmid, H., Riel, H., Riess, W.

Volltext

Acquired Resistance to Targeted Therapies Against Oncogene-Driven Non–Small-Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications von Gandara, David R, Li, Tianhong, Lara, Primo N, Kelly, Karen, Riess, Jonathan W, Redman, Mary W, Mack, Philip C

Volltext

Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC von Goldberg, Michael E, Montesion, Meagan, Young, Lauren, Suh, James, Greenbowe, Joel, Kennedy, Mark, Giaccone, Giuseppe, Akerley, Wallace L, Dowlati, Afshin, Creelan, Benjamin C, Hicks, James K, Hesketh, Paul J, Kelly, Karen L, Riess, Jonathan W, Miller, Vincent A, Stephens, Philip J, Frampton, Garrett M, Ali, Siraj, Gregg, Jeffrey P, Albacker, Lee A

Volltext

Lateral Strain Profile as Key Technology Booster for All-Silicon Tunnel FETs von Boucart, K., Riess, W., Ionescu, A.M.

Volltext

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score = 50 von Reck, Martin, Rodriguez-Abreu, Delvys, Robinson, Andrew G., Hui, Rina, Csoszi, Tibor, Fulop, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Leal, Ticiana A., Riess, Jonathan W., Jensen, Erin, Zhao, Bin, Pietanza, M. Catherine, Brahmer, Julie R.

Volltext

Tuning the emission characteristics of top-emitting organic light-emitting devices by means of a dielectric capping layer: An experimental and theoretical study von Riel, H., Karg, S., Beierlein, T., Rieß, W., Neyts, K.

Volltext